Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 6, 1996, Pages 601-607

  Hellriegel, E T ^a   Bjornsson, T D ^a   Hauck, W W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; BIOAVAILABILITY; BIOEQUIVALENCE; DRUG ABSORPTION; DRUG DESIGN; FOOD AND DRUG ADMINISTRATION; HUMAN; PATIENT; PRIORITY JOURNAL; SHORT SURVEY;

ADULT; ANTI-INFECTIVE AGENTS; BIOLOGICAL AVAILABILITY; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; THERAPEUTIC EQUIVALENCY;

EID: 0030444901     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90208-8     Document Type: Short Survey

References (13)